Here are relevant reports on : influenza-vaccine-market
-
Cryo-electron Microscopy Market by Product & Service (Instruments, Software, Services), Technology (Electron Crystallography, Cryo-ET), Voltage (300 kV), Application (Cancer, Omics, Gene Therapy, Nanotechnology, Vaccine) & Region - Global Forecasts to 2028
The global cryo-electron microscopy market in terms of revenue was estimated to be worth $1.1 billion in 2022 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 11.6% from 2022 to 2028. As of 2021, prominent players in the global market are Thermo Fisher Scientific (US), Danaher (US), JEOL Ltd. (Japan), Intertek Group Plc (UK), and Charles River Laboratories (US).
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Immunotherapy Drugs Market by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
The global immunotherapy drugs market, valued at US$255.9 billion in 2023, stood at US$285.3 billion in 2024 and is projected to advance at a resilient CAGR of 15.3% from 2024 to 2029, culminating in a forecasted valuation of US$580.6 billion by the end of the period. This growth is driven by technological advancements in antibody engineering, increasing demand for antibody therapies in clinical cancer treatment, and a growing preference for personalized medicines and targeted therapies.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Sterile Filtration Market by Product (Cartridge, Capsule Filter), Application (API, Vaccine, Antibody, Media, Formulation & Fill Finish), Membrane (PES, PVDF, PTFE), Pore Size, End User (Pharma & Biotech, F&B, CMO) - Global Forecast to 2028
The global sterile filtration market, valued at US$8.2 billion in 2022, stood at US$8.9 billion in 2023 and is projected to advance at a resilient CAGR of 11.4% from 2023 to 2028, culminating in a forecasted valuation of US$15.3 billion by the end of the period. The growth of this market is majorly driven by demand for sterile filtration in pharmaceutical companies and the food and beverage industries.
- Published: April 2023
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Manufacturing Software Market by Offering (AI-Integrated), Type (MES, SCADA, Quality Compliance, EPR, Track & Trace), Application (Biologics, Vaccine), End User (Pharma, Biotech, CDMO), Trend, Growth, Market Share - Global Forecast to 2030
The global Pharmaceutical Manufacturing Software market, valued at US$3.10 billion in 2024, stood at US$3.41 billion in 2025 and is projected to advance at a resilient CAGR of 10.1% from 2025 to 2030, culminating in a forecasted valuation of US$5.52 billion by the end of the period. The development is largely predetermined by the rise in regulatory compliance and the need to use digital and automated manufacturing solutions, the necessity to provide data integrity and traceability, and the increased need to produce pharmaceuticals worldwide.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020
The global virus filtration market size is projected to grow at a CAGR of 12.3%. Virus filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.
- Published: April 2016
- Price: $ 4950
- TOC Available:
-
Cancer Vaccines Market by Type (Preventive, Therapeutic (Neoantigen)), Technology (Cell-based Vaccine, Recombinant), Indication (Cervical, Prostate), ROA (Intramuscular, Intravenous), End User (Hospitals, Speciality Clinics) - Global Forecast to 2032
The global cancer vaccines market, valued at US$9.70 billion in 2023, stood at US$9.84 billion in 2024 and is projected to advance at a resilient CAGR of 5.4% from 2024 to 2032, culminating in a forecasted valuation of US$15.00 billion by the end of the period. The cancer vaccines market is growing rapidly, fueled by rising prevalence of cancer, technological advancements in immunotherapy, and increasing adoption of preventive healthcare across the globe.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
North America Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The North America Cell Culture Market, valued at US$11.10 billion in 2024, stood at US$11.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$20.38 billion by the end of the period. Growth of the North America cell culture market is driven by a strong and expanding biopharmaceutical industry, with rising production of biologics such as monoclonal antibodies, vaccines, and cell-based therapies that rely heavily on advanced culture techniques and systems.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Process Analytical Technology Market Size by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), and End User - Global Forecast to 2029
The global biopharmaceutical process analytical technology market, valued at US$1.0 billion in 2023, stood at US$1.2 billion in 2024 and is projected to advance at a resilient CAGR of 16.0% from 2024 to 2029, culminating in a forecasted valuation of US$2.6 billion by the end of the period. The market is witnessing a surge in growth propelled by rising investments, both direct and indirect, in analytical instruments, coupled with strategic partnerships aimed at advancing drug discovery.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Beads (Natural (Collagen), Synthetic (Polystyrene)), Application (Vaccine, CGT, Stem Cells) - Global Forecast to 2029
The global microcarriers market, valued at US$2.03B in 2023, is forecasted to grow at a 8.0% CAGR, reaching US$2.08B by 2024 and US$3.05B by 2029. Market growth is attributed to rising investments in cell & gene therapy research, growing preference for single-use technologies, and increasing R&D spending for biopharmaceutical production.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Infectious Disease Immunoassay Market by Product & Services (Reagents and kits, Analysers & Software and Services), Platform (CLIA, FIA, CI, RIA), Specimen Type, Disease (Hepatitis, HIV, CT/NG, HPV, TB, Influenza) & End User - Global Forecast to 2023
The global infectious disease immunoassay market is expected to reach USD 2,233.0 million by 2023 from USD 1,642.5 million in 2018, growing at a CAGR of 6.3%. Increasing incidence of chronic and infectious diseases; technological advancements in immunoassay instruments and the introduction of novel automated systems; growth in biotechnology and biopharmaceutical industries; increasing adoption of immunoassay-based point-of-care testing and rapid testing are some of the major factors driving the growth of the global infectious disease immunoassay market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: April 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
